Valneva SE
- Biotech or pharma, therapeutic R&D
Valneva is a specialty vaccine company focused on prevention against diseases with major unmet needs. Valneva’s portfolio includes three commercial vaccines and a unique Phase 3 vaccine candidate in development against Lyme disease (partnered with Pfizer) as well as a Shigella vaccine in Phase 2, Zika vaccine in Phase 1, and other preclinical assets.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}